<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Biol. Chem</journal-id>
<journal-id journal-id-type="hwp">jbc</journal-id>
<journal-id journal-id-type="pmc">jbc</journal-id>
<journal-id journal-id-type="publisher-id">JBC</journal-id>
<journal-title-group>
<journal-title>The Journal of Biological Chemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9258</issn>
<issn pub-type="epub">1083-351X</issn>
<publisher>
<publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name>
<publisher-loc>11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A.</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26994141</article-id>
<article-id pub-id-type="pmc">4900273</article-id>
<article-id pub-id-type="publisher-id">M115.703868</article-id>
<article-id pub-id-type="doi">10.1074/jbc.M115.703868</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurobiology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Identification of Amino Acid Residues in Fibroblast Growth Factor 14 (FGF14) Required for Structure-Function Interactions with Voltage-gated Sodium Channel Nav1.6<xref ref-type="fn" rid="FN1">*</xref></article-title>
<alt-title alt-title-type="short">FGF14 Structure-Function Interactions with Nav1.6</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ali</surname>
<given-names>Syed R.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>§</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Singh</surname>
<given-names>Aditya K.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Laezza</surname>
<given-names>Fernanda</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>¶</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>‖</sup>
</xref>
<xref ref-type="aff" rid="aff5">**</xref>
<xref ref-type="aff" rid="aff6">
<sup>‡‡</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1">From the <label>‡</label>Department of Pharmacology and Toxicology, </aff>
<aff id="aff2">the <label>§</label>Pharmacology and Toxicology Graduate Program, </aff>
<aff id="aff3">the <label>¶</label>Mitchell Center for Neurodegenerative Diseases, </aff>
<aff id="aff4">the <label>‖</label>Center for Addiction Research, </aff>
<aff id="aff5">the <label>**</label>Center for Environmental Toxicology, and </aff>
<aff id="aff6">the <label>‡‡</label>Center for Biomedical Engineering, University of Texas Medical Branch, Galveston, Texas 77555</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>1</label> To whom correspondence should be addressed: <addr-line>Dept. of Pharmacology and Toxicology, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555.</addr-line> Tel.: <phone>409-772-9672</phone>; Fax: <fax>409-772-9642</fax>; E-mail: <email>felaezza@utmb.edu</email>.</corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>20</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>3</month>
<year>2016</year>
</pub-date>
<volume>291</volume>
<issue>21</issue>
<fpage>11268</fpage>
<lpage>11284</lpage>
<history>
<date date-type="received">
<day>17</day>
<month>11</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>14</day>
<month>3</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>The American Society for Biochemistry and Molecular Biology, Inc.</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="zbc02116011268.pdf"></self-uri>
<abstract>
<p>The voltage-gated Na<sup>+</sup> (Nav) channel provides the basis for electrical excitability in the brain. This channel is regulated by a number of accessory proteins including fibroblast growth factor 14 (FGF14), a member of the intracellular FGF family. In addition to forming homodimers, FGF14 binds directly to the Nav1.6 channel C-tail, regulating channel gating and expression, properties that are required for intrinsic excitability in neurons. Seeking amino acid residues with unique roles at the protein-protein interaction interface (PPI) of FGF14·Nav1.6, we engineered model-guided mutations of FGF14 and validated their impact on the FGF14·Nav1.6 complex and the FGF14:FGF14 dimer formation using a luciferase assay. Divergence was found in the β-9 sheet of FGF14 where an alanine (Ala) mutation of Val-160 impaired binding to Nav1.6 but had no effect on FGF14:FGF14 dimer formation. Additional analysis revealed also a key role of residues Lys-74/Ile-76 at the N-terminal of FGF14 in the FGF14·Nav1.6 complex and FGF14:FGF14 dimer formation. Using whole-cell patch clamp electrophysiology, we demonstrated that either the FGF14<sup>V160A</sup> or the FGF14<sup>K74A/I76A</sup> mutation was sufficient to abolish the FGF14-dependent regulation of peak transient Na<sup>+</sup> currents and the voltage-dependent activation and steady-state inactivation of Nav1.6; but only V160A with a concomitant alanine mutation at Tyr-158 could impede FGF14-dependent modulation of the channel fast inactivation. Intrinsic fluorescence spectroscopy of purified proteins confirmed a stronger binding reduction of FGF14<sup>V160A</sup> to the Nav1.6 C-tail compared with FGF14<sup>K74A/I76A</sup>. Altogether these studies indicate that the β-9 sheet and the N terminus of FGF14 are well positioned targets for drug development of PPI-based allosteric modulators of Nav channels.</p>
</abstract>
<kwd-group>
<kwd>amino acid</kwd>
<kwd>electrophysiology</kwd>
<kwd>fibroblast growth factor (FGF)</kwd>
<kwd>ion channel</kwd>
<kwd>protein-protein interaction</kwd>
<kwd>FGF14</kwd>
<kwd>Nav1.6</kwd>
<kwd>hot spots</kwd>
<kwd>split-luciferase assay</kwd>
<kwd>voltage-gated sodium channels</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>National Institutes of Health
<named-content content-type="funder-id">http://dx.doi.org/10.13039/100000002</named-content></funding-source>
<award-id>R01MH095995</award-id>
</award-group>
<award-group id="award2">
<funding-source>National Institute of General Medical Sciences
<named-content content-type="funder-id">http://dx.doi.org/10.13039/100000057</named-content></funding-source>
<award-id>T32 GM089657-04</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>